Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis.

Campbell, Kirk N; Pennese, Natali; Zaffalon, Andrea; Magalhaes, Barbara; Faiella, Marina; Caster, Dawn J; Radhakrishnan, Jai; Tesar, Vladimir; Trachtman, Howard

Campbell, Kirk N; Pennese, Natali; Zaffalon, Andrea; Magalhaes, Barbara; Faiella, Marina; Caster, Dawn J; Radhakrishnan, Jai; Tesar, Vladimir; Trachtman, Howard.

Afiliação

Campbell KN; Icahn School of Medicine at Mount Sinai, New York, NY.
Pennese N; LatticePoint Consulting, Geneva, Switzerland.
Zaffalon A; LatticePoint Consulting, Geneva, Switzerland.
Magalhaes B; LatticePoint Consulting, Geneva, Switzerland.
Faiella M; LatticePoint Consulting, Geneva, Switzerland.
Caster DJ; University of Louisville School of Medicine, Louisville, KY.
Radhakrishnan J; Columbia University Medical Center, New York, NY.
Tesar V; Charles University, General University Hospital, Prague, Czech Republic.
Trachtman H; NYU Grossman School of Medicine, NYU Langone Health, New York, NY.

Kidney Med ; 4(5): 100457, 2022 May.

Article em En | MEDLINE | ID: mdl-35518835

Palavras-chave

End-stage kidney disease; end-stage renal disease; focal segmental glomerulosclerosis; proteinuria; renin-angiotensin-aldosterone system inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Kidney Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google